Literature DB >> 6874385

Renal amyloidosis complicating a recessive epidermolysis bullosa in childhood.

S Málaga, J Fernández Toral, F Santos, I Riesgo, M Crespo.   

Abstract

A case of recessive epidermolysis bullosa and secondary renal amyloidosis in a nine-year-old boy is reported. The first case observed in childhood. The clinical relationships of the two conditions are briefly discussed.

Entities:  

Mesh：

Year:  1983        PMID： 6874385

Source DB:  PubMed          Journal:  Helv Paediatr Acta        ISSN： 0018-022X


  5 in total

Review 1.  Epidermolysis bullosa and the partnership with autoimmunity: what should we assimilate?

Authors:  Susanna Esposito; Sophie Guez; Francesca Manzoni; Annalisa Bosco; Donato Rigante
Journal:  Immunol Res       Date:  2015-02       Impact factor: 2.829

2.  End-stage renal disease secondary to IgA nephropathy in recessive dystrophic epidermolysis bullosa: a case report.

Authors:  Fabiana Tammaro; Raffaele Calabrese; Gabriella Aceto; Lucia Lospalluti; Lucrezia Garofalo; Ernesto Bonifazi; Tiziana Piccolo; Giovanni Pannarale; Rosa Penza
Journal:  Pediatr Nephrol       Date:  2007-10-23       Impact factor: 3.714

Review 3.  A Review of Acquired Autoimmune Blistering Diseases in Inherited Epidermolysis Bullosa: Implications for the Future of Gene Therapy.

Authors:  Payal M Patel; Virginia A Jones; Christy T Behnam; Giovanni Di Zenzo; Kyle T Amber
Journal:  Antibodies (Basel)       Date:  2021-05-17

4.  Autoimmunity and Cytokine Imbalance in Inherited Epidermolysis Bullosa.

Authors:  Susanna Esposito; Sophie Guez; Annalisa Orenti; Gianluca Tadini; Giulietta Scuvera; Laura Corti; Alessia Scala; Elia Biganzoli; Emilio Berti; Nicola Principi
Journal:  Int J Mol Sci       Date:  2016-09-24       Impact factor: 5.923

5.  Diffuse membranoproliferative glomerulonephritis with focal sclerosis and renal amyloidosis in an adult male with autosomal dominant dystrophic epidermolysis bullosa: a case report.

Authors:  Karim M Soliman; Tibor Fülöp; David W Ploth; Johann Herberth
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.